| PeptiSystems AB. (5/15/25). "Press Release: PeptiSystems and Asahi Kasei Bioprocess America Enter Exclusive Global Partnership for Peptide Synthesis". Uppsala. |
2025-05-15 |
| Lonza Group AG. (5/15/25). "Press Release: Lonza Appoints Andreas Bohrer as Chief Legal & Corporate Affairs Officer". Basel. |
2025-05-15 |
| Agilent Technologies Inc.. (5/14/25). "Press Release: Agilent Partners Ubix Therapeutics to Advance Transformative Cancer Research in South Korea". Seoul. |
2025-05-14 |
| Agilent Technologies Inc.. (5/8/25). "Press Release: Agilent Inaugurates India Solution Center to Accelerate Innovation and Expand the Frontiers of Science". Manesar. |
2025-05-08 |
| Bruker Corporation. (5/7/25). "Press Release: Bruker Reports First Quarter 2025 Financial Results". Billerica, MA. |
2025-05-07 |
| Nuevocor. (5/6/25). "Press Release: Nuevocor Closes US$45 Million Series B Financing for Clinical Development of Novel Mechanobiology-Centered Therapy for Cardiomyopathy". Singapore & Philadelphia, PA. |
2025-05-06 |
| Regeneron Pharmaceuticals, Inc.. (4/22/25). "Press Release: Regeneron Announces New Investment in Manufacturing of its Industry-Leading Biologic Medicines". Tarrytown, NY. |
2025-04-22 |
| Earendil Labs. (4/17/25). "Press Release: Earendil Labs Announces Worldwide Exclusive License Agreement with Sanofi for Next-Generation Bispecific Antibodies for Autoimmune and Inflammatory Bowel Diseases". Middletown, DE. |
2025-04-17 |
| Glycomine, Inc.. (4/16/25). "Press Release: Glycomine Announces $115 Million Series C Financing to Advance Lead Drug Candidate, GLM101, into a Phase 2b Clinical Trial for PMM2-CDG". San Carlos, CA. |
2025-04-16 |
| ExpreS2ion Biotech Holding AB. (4/15/25). "Press Release: ExpreS2ion Signs Letter of Intent with WuXi Vaccines to Initiate Technology Evaluation of ExpreS2ion’s Proprietary Production Platform ExpreS2". Hørsholm. |
2025-04-15 |
| Chromatin Bioscience Ltd.. (4/14/25). "Press Release: Chromatin Bioscience Signs Collaboration Agreement with Astellas". Edinburgh. |
2025-04-14 |
| Braskem S.A.. (4/10/25). "Press Release: Braskem Siam and Mitr Phol Bio Fuel Sign Letter of Intent for Ethanol Supply for Upcoming Bio-ethylene Plant in Thailand". Bangkok. |
2025-04-10 |
| Sphere Bio Ltd.. (4/9/25). "Press Release: APAC Distribution Network Expanded to Strengthen Presence in Region". Cambridge. |
2025-04-09 |
| Neurona Therapeutics. (4/3/25). "Press Release: Neurona Therapeutics Raises $102 Million to Fuel NRTX-1001 Phase 3 EPIC Epilepsy Trial and Advance Regenerative Cell Therapy Pipeline". South San Francisco, CA. |
2025-04-03 |
| Singleron Biotechnologies GmbH. (3/31/25). "Press Release: Singleron Introduces PythoN i, Adding Nuclei Extraction and Tissue Homogenization Functions to its Tissue Processing System". Cologne. |
2025-03-31 |
| Singleron Biotechnologies GmbH. (3/27/25). "Press Release: Singleron Biotechnologies Launches MobiuSCOPE – a Simple Solution for High-Throughput Full-Length Single Cell RNA Sequencing". Cologne. |
2025-03-27 |
| Bayer AG. (3/26/25). "Press Release: Bayer and Puhe BioPharma Enter into Global License Agreement for Clinical Phase I PRMT5 inhibitor [Not intended for U.S. and UK Media]". Berlin & Beijing. |
2025-03-26 |
| Genmab A/S. (3/22/25). "Press Release: Genmab to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc.". Copenhagen. |
2025-03-22 |
| AstraZeneca plc. (3/21/25). "Press Release: AstraZeneca to Invest $2.5 Billion in New Global Strategic R&D Centre, Biotech Agreements and Manufacturing in Beijing". |
2025-03-21 |
| [iito] Business Intelligence. (3/18/25). "Press Release: [iito] Business Intelligence Announces Major Changes in Its Social Media Strategy". Bremen. |
2025-03-18 |
| Vivesto AB. (3/18/25). "Press Release: Vivesto Licenses Apealea to China’s Zhida Pharmaceutical". Solna. |
2025-03-18 |
| RegCell, Inc.. (3/18/25). "Press Release: Japanese-Founded Regulatory T-cell Reprogramming Company RegCell Secures $45.8M in Funding and Completes U.S. Headquarters Transition". Emeryville, CA. |
2025-03-18 |
| Araris Biotech AG. (3/17/25). "Press Release: Taiho Pharmaceutical to Acquire Next-Generation ADC Drug Discovery Company Araris Biotech". |
2025-03-17 |
| AstraZeneca plc. (3/17/25). "Press Release: AstraZeneca Enters License Agreement with Alteogen for Subcutaneous Formulations of Multiple Oncology Assets". |
2025-03-17 |
| Insilico Medicine. (3/13/25). "Press Release: Insilico Medicine Secures $110 Million Series E Financing to Advance AI-Driven Drug Discovery Innovation". Cambridge, MA. |
2025-03-13 |
| C2N Diagnostics, LLC. (3/13/25). "Press Release: Samsung Invests in C2N Diagnostics. Partnership to Expand C2N’s Commercial Scale and Innovation Pipeline". St. Louis, MO. |
2025-03-13 |
| Valo Therapeutics Oy. (3/10/25). "Press Release: Valo Therapeutics Announces EUR 19m of Investment Funding and Expanded Clinical Trials". Helsinki, Naples & Perth. |
2025-03-10 |
| Sun Pharmaceutical Industries Ltd.. (3/10/25). "Press Release: Sun Pharma to Acquire Checkpoint Therapeutics". Mumbai & Waltham, MA. |
2025-03-10 |
| Salipro Biotech AB. (3/5/25). "Press Release: Collaboration and Licensing Agreement with Top Tier South Korean Pharma Company". |
2025-03-05 |
| Trimtech Therapeutics Ltd.. (3/5/25). "Press Release: Trimtech Therapeutics Raises $31M Seed Funding to Advance Targeted Protein Degradation Pipeline for Treatment of Neurodegenerative Diseases". Cambridge. |
2025-03-05 |
| Boehringer Ingelheim. (3/4/25). "Press Release: Boehringer Ingelheim Enhances Biopharmaceutical Contract Manufacturing Services in China". Ingelheim. |
2025-03-04 |
| Callio Therapeutics. (3/3/25). "Press Release: Callio Therapeutics Launches with US$187 Million Series A to Advance Multi-Payload Antibody-Drug Conjugate Platform Through Clinical Proof-of-Concept". Seattle, WA & Singapore. |
2025-03-03 |
| Medigene AG. (2/27/25). "Press Release: Medigene and EpimAb Biotherapeutics Enter into a Co-Development Partnership for TCR-Guided T Cell Engagers". Planegg. |
2025-02-27 |
| Enveda. (2/26/25). "Press Release: Enveda Gains Backing from Sanofi to Advance AI-Driven Drug Discovery to Clinical Trials Bringing Total Series C Financing to $150M". Boulder, CO. |
2025-02-26 |
| Adcendo ApS. (2/26/25). "Press Release: Adcendo ApS Announces U.S. FDA Clearance of IND Application for Phase I Tiffany-01 Trial of ADCE-T02". Copenhagen. |
2025-02-26 |
| Thermo Fisher Scientific Inc.. (2/25/25). "Press Release: Thermo Fisher Scientific to Acquire Solventum’s Purification and Filtration Business". Waltham, MA. |
2025-02-25 |
| Ion Opticks Pty Ltd.. (2/24/25). "Press Release: IonOpticks Announces Strategic Global Expansion with Key Leadership Appointments". Melbourne. |
2025-02-24 |
| FibroGen, Inc.. (2/20/25). "Press Release: FibroGen Announces the Sale of FibroGen China to AstraZeneca for Approximately $160 Million". San Francisco, CA. |
2025-02-20 |
| Anbio Biotechnology. (2/20/25). "Press Release: Anbio Biotechnology Announces Closing of Initial Public Offering". Frankfurt a. M.. |
2025-02-20 |
| Anbio Biotechnology. (2/18/25). "Press Release: Anbio Biotechnology Announces Pricing of Initial Public Offering". Frankfurt a. M.. |
2025-02-18 |
| Qiagen N.V.. (2/13/25). "Press Release: Qiagen Strengthens Global Bioinformatics Leadership With New Data Center in Australia/Asia-Pacific Region". Venlo & Redwood City, CA. |
2025-02-13 |
| Mitsubishi Chemical Group Corporation. (2/7/25). "Press Release: Notice Concerning the Transfer of Mitsubishi Tanabe Pharma
Corporation and its Subsidiaries
". |
2025-02-07 |
| Bain Capital, LP. (2/7/25). "Press Release: Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation". Tokyo & Boston, MA. |
2025-02-07 |
| Becton, Dickinson and Company. (2/5/25). "Press Release: BD Announces Intent to Separate Biosciences and Diagnostic Solutions Business to Enhance Focus, Drive Growth and Unlock Value". Franklin Lakes, NJ. |
2025-02-05 |
| Stryker. (1/28/25). "Press Release: Stryker Announces Definitive Agreement for the Sale of its U.S. Spinal Implants Business and Plans to Sell Related International Business". Portage, MI. |
2025-01-28 |
| SGS S.A.. (1/15/25). "Press Release: Statement. Following Recent Media Commentary SGS Indicates that It Is in Discussions with Bureau Veritas Regarding a Potential Business Combination". |
2025-01-15 |
| Eckert & Ziegler SE. (1/14/25). "Press Release: Eckert & Ziegler Signs Licence Agreement for Actinium-225 with Chinese Joint Venture". Berlin. |
2025-01-14 |
| Umoja Biopharma, Inc.. (1/14/25). "Press Release: Umoja Biopharma Announces Oversubscribed $100 Million Series C Financing to Advance In Vivo CAR T Pipeline through Key Oncology Clinical Milestones". Seattle, WA. |
2025-01-14 |
| BioMed X GmbH. (1/14/25). "Press Release: BioMed X Institute Launches New Collaboration with Daiichi Sankyo in Cancer Therapy". Heidelberg. |
2025-01-14 |
| Bioptimus SAS. (1/14/25). "Press Release: Bioptimus Hits $76M Funding Milestone and Prepares to Launch Groundbreaking Foundation Model for Biology". |
2025-01-14 |
| Daiichi Sankyo Co., Ltd.. (1/13/25). "Press Release: Daiichi Sankyo Acquires Intellectual Property Rights for Anti-TA-MUC1 Antibody in DS-3939 from Glycotope GmbH". Tokyo & Basking Ridge, NJ. |
2025-01-13 |
| Eckert & Ziegler SE. (1/13/25). "Press Release: Eckert & Ziegler and GlyTherix Extend Collaboration with Actinium-225 Supply Agreement". Berlin & Sydney. |
2025-01-13 |
| Normunity, Inc.. (1/13/25). "Press Release: Normunity Closes $75 million Series B Financing to Advance Lead Drug Program into the Clinic and Broaden Pipeline of Novel Anti-cancer Therapies Targeting Untapped Drug Mechanisms". Boston, MA & New Haven, CT. |
2025-01-13 |
| Candid Therapeutics, Inc.. (1/13/25). "Press Release: Candid Therapeutics Enters into Agreement with WuXi Biologics on Trispecific T-cell Engager". New Brunswick, NJ & Bedminster, NJ. |
2025-01-13 |
| Windward Bio AG. (1/10/25). "Press Release: Windward Bio Launches With $200 Million Series A Financing to Develop Phase 2-Ready, Long-Acting Anti-TSLP Antibody With Best-in-Class Potential in Asthma and COPD". Basel. |
2025-01-10 |
| EsoBiotec SA. (1/8/24). "Press Release: EsoBiotec Doses First Patient in Investigator Initiated Trial of In Vivo BCMA CAR-T Candidate ESO-T01 for Multiple Myeloma". Mont-Saint-Guibert. |
2025-01-08 |
| Innovent Biologics, Inc.. (1/2/25). "Press Release: Innovent Enters into Exclusive Global License Agreement with Roche for Novel DLL3 Antibody Drug Conjugate". San Francisco, CA & Suzhou. |
2025-01-02 |
| BeiGene, Ltd.. (12/23/24). "Press Release: BeiGene to Change Nasdaq Ticker Symbol to “ONC” on January 2; Present at 43rd Annual J.P. Morgan Healthcare Conference". San Mateo, CA. |
2024-12-23 |
| Innovent Biologics, Inc.. (12/20/24). "Press Release: Innovent Receives Approval of Dovbleron (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China’s National Medical Products Administration". San Francisco, CA & Suzhou. |
2024-12-20 |
| Sangamo Therapeutics, Inc.. (12/19/24). "Press Release: Sangamo Therapeutics and Astellas Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases". Richmond, CA & Tokyo. |
2024-12-19 |
| Innovent Biologics, Inc.. (12/16/24). "Press Release: Innovent and Lilly Expand Collaboration Through Agreement on Commercialization Rights for Jaypirca (pirtobrutinib) in Mainland China". San Francisco, CA, Indianapolis, IN & Suzhou. |
2024-12-16 |
| Eckert & Ziegler SE. (12/13/24). "Press Release: Eckert & Ziegler Submits GalliaPharm for Approval by Japan’s Health Authority MHLW". Berlin. |
2024-12-13 |
| Angitia Biopharmaceuticals Ltd.. (12/11/24). "Press Release: Angitia Biopharmaceuticals Announces $120 Million Series C Financing". Woodland Hills, CA. |
2024-12-11 |
| Syncell, Inc.. (12/11/24). "Press Release: Syncell Announces $ 15 Million Series A Funding to Accelerate the Global Commercial Growth Of ITS Protein Purification And Spatial Proteomics Technology". Taipei & Watertown, MA. |
2024-12-11 |
| EsoBiotec SA. (12/11/24). "Press Release: EsoBiotec Begins Clinical Trial of In Vivo BCMA CAR-T Candidate ESO-T01 for Multiple Myeloma". Mont-Saint-Guibert. |
2024-12-11 |
| Formycon AG. (12/9/24). "Press Release: MS Pharma Becomes Partner for the Commercialization of FYB202 / Ustekinumab in the MENA Region". Planegg-Martinsried. |
2024-12-09 |
| Ion Opticks Pty Ltd.. (12/5/24). "Press Release: IonOpticks’ Custom Chromatography Column to Become Biognosys’ Standard for High-quality Proteomic Insights". Melbourne. |
2024-12-05 |
| Medigene AG. (11/26/24). "Press Release: Medigene AG Announces Refocus of Corporate Strategy and Organizational Realignment". Basel. |
2024-11-26 |
| Adragos Pharma GmbH. (11/25/24). "Press Release: Adragos Pharma Acquires Baccinex – a Leading Swiss Sterile Fill-Finish Expert". Munich & Courroux. |
2024-11-25 |
| Agilent Technologies Inc.. (11/25/24). "Press Release: Agilent Reports Fourth-Quarter Fiscal Year 2024 Financial Results". Santa Clara, CA. |
2024-11-25 |
| Agilent Technologies Inc.. (11/25/24). "Press Release: Agilent Announces New Organizational Structure to Support its Market-Focused Strategy". Santa Clara, CA. |
2024-11-25 |
| Enveda. (11/21/24). "Press Release: Enveda Closes $130M Series C Funding to Deliver Multiple Clinical Readouts from a Pipeline of 10 Development Candidates". Boulder, CO. |
2024-11-21 |
| [iito] Business Intelligence / Kääb, Georg [ Itranskript ]. (11/13/24). "[LSG] Newsletter Special Issue: DACH Region Seed Financings 2020–2024. A List of 104 Deals with Comment & Analysis by Georg Kääb". Bremen & München. |
2024-11-13 |
| BioNTech SE. (11/13/24). "Press Release: BioNTech to Acquire Biotheus to Boost Oncology Strategy". Mainz. |
2024-11-13 |
| Alentis Therapeutics AG. (11/12/24). "Press Release: Alentis Therapeutics Raises $181.4 Million in an Oversubscribed Series D Financing to Advance the Clinical Development of Anti-Claudin-1 ADCs in Solid Tumors". Basel. |
2024-11-12 |
| Ion Opticks Pty Ltd.. (10/25/24). "Press Release: Sciex and IonOpticks Announce Co-Marketing Agreement Between Aurora Series XS Range and the ZenoTOF Line". Melbourne. |
2024-10-25 |
| |transkript [Kääb, Georg]. (10/21/24). "Miltenyi Biotec: An Exclusive, Rare Interview with Founder Stefan Miltenyi. Interview by |transkript.de/Georg Kääb". |
2024-10-21 |
| Nuclera Ltd.. (10/16/24). "Press Release: Nuclera Closes $75 Million USD Financing
> Series C round led by Elevage Medical Technologies". Cambridge & Boston, MA. |
2024-10-16 |
| Yumab GmbH. (10/8/24). "Press Release: Yumab and Molcure Collaborate To Advance Zero-Shot AI Antibody Discovery Technology For Undrugged Targets". |
2024-10-08 |
| Innovent Biologics, Inc.. (10/8/24). "Press Release: Innovent and Ask Pharm Announce Strategic Collaboration for Limertinib, a Third-generation EGFR TKI for the Treatment of Lung Cancer". San Francisco, CA & Suzhou. |
2024-10-08 |
| Mérieux NutriSciences Corporation. (10/7/24). "Press Release: Mérieux NutriSciences Enters Agreement to Acquire Worldwide Food Testing Business of Bureau Veritas". Chicago, IL. |
2024-10-07 |
| Agilent Technologies Inc.. (10/4/24). "Press Release: Agilent and the National University of Singapore Launch Center of Excellence in Cell Metabolism to Improve Population Health". Singapore. |
2024-10-04 |
| Kurma Partners. (10/3/24). "Press Release: Kurma Partners Achieves First Close of New EUR 250 Million Biofund IV". Paris. |
2024-10-03 |
| Regor Pharmaceuticals (USA). (9/30/24). "Press Release: Regor Enters into a Definitive Purchase Agreement for Genentech to Acquire Regor's Portfolio of Next-generation CDK Inhibitors for the Treatment of Breast Cancer". Cambridge, MA. |
2024-09-30 |
| Tempus AI, Inc.. (9/26/24). "Press Release: Tempus Announces Expansion of Collaboration with Takeda to Leverage Multimodal Real-world Datasets and Biological Model Systems in Oncology Research and Development". Chicago, IL. |
2024-09-26 |
| Resonac Corporation. (9/24/24). "Press Release: Resonac Corporation Signs Contract to Transfer Shares of Minaris Regenerative Medicine Subsidiaries to Altaris". Zwingenberg. |
2024-09-24 |
| Minaris Regnerative Medicine GmbH. (9/24/24). "Press Release: Minaris Regenerative Medicine Announces Agreement to be Acquired by Altaris". Yokohama, Munich & Allendale, NJ. |
2024-09-24 |
| Aptadir Therapeutics. (9/24/24). "Press Release: Launch of Aptadir Therapeutics With a Novel Class of RNA Inhibitors". Milan. |
2024-09-24 |
| Symrise AG. (9/20/24). "Press Release: Symrise and Shan Foods Inaugurate a State-of-the-Art International Standard Production Facility for Its Strategic Partnership in Pakistan". Dubai, Holzminden & Karachi. |
2024-09-20 |
| Bioké (Cell Signaling Technology Europe B.V.). (9/16/24). "Press Release: Bioké and e-Blot Announce a Distribution Agreement in the European Region". Leiden. |
2024-09-16 |
| Organon & Co.. (9/12/24). "Press Release: Organon Enters into Licensing Agreement with Bao Pharmaceutical and Its Wholly-owned Subsidiary Centergene Pharmaceuticals". Shanghai. |
2024-09-12 |
| Abolis Biotechnologies SAS. (9/12/24). "Press Release: Abolis Biotechnologies Secures 35 Mio. Euro from International Consortium of Industrials and Funds". Èvry-Courcouronnes. |
2024-09-12 |
| Singleron Biotechnologies. (9/11/24). "Press Release: Singleron Launches New All-in-One sCelLiVE Tissue Dissociation Kit for Skin". Cologne. |
2024-09-11 |
| PhoreMost Ltd.. (9/10/24). "Press Release: PhoreMost Extends Series B Financing to $50M to Advance High-value Oncology and Inflammation Degrader Programmes". Cambridge. |
2024-09-10 |
| Ion Opticks Pty Ltd.. (9/10/24). "Press Release: IonOpticks Partners with Adelis to Accelerate Global Expansion and Innovation". Melbourne & Stockholm. |
2024-09-10 |
| Oxford Nanopore Technologies plc. (9/10/24). "Press Release: Oxford Nanopore Seeks Discovery in Connection with Anticipated Breach of Contract Action". |
2024-09-10 |
| Candid Therapeutics, Inc.. (9/9/24). "Press Release: Candid Therapeutics Debuts with $370M Capital Raise to Clinically Evaluate Potentially Transformative Autoimmune Therapies". San Diego, CA. |
2024-09-09 |
| Körber Pharma. (9/4/24). "Press Release: Körber Reaches Strategic Partnership with Taibang Biologic to Future-proof Blood Product Manufacturing and Increase Production Efficiency". Lüneburg & Tai’an. |
2024-09-04 |
| EpimAb Biotherapeutics, Inc.. (9/4/24). "Press Release: EpimAb Biotherapeutics and Vignette Bio Announce Strategic Collaboration to Develop EMB-06, a BCMA×CD3 Bispecific Antibody". Shanghai & San Diego, CA. |
2024-09-04 |
| eGenesis Inc.. (9/4/24). "Press Release: eGenesis Raises $191 Million Series D Financing to Advance Lead Program for Kidney Transplant". Cambridge, MA. |
2024-09-04 |
![[LSA] Life-Sciences-Asia.com - The East-West Life Sciences Web Portal](/images/basics/lsa-life-sciences-asia-portal-logo.svg){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
